Enzymatic Pathogen Detection via Papain-Like Protease Cleavage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting SARS-CoV-2 and other coronaviruses are inefficient, prone to false negatives, require specialized equipment, and cannot differentiate between active and inactive viral fragments, making them unsuitable for rapid and accurate diagnosis, especially in clinical settings.
Innovation Solution
A method involving a peptide substrate with a signaling moiety, specifically designed to be cleaved by papain-like proteases, which generates a fluorescent signal when cleaved, allowing for rapid detection of active viral infections using a lateral flow assay or enzymatic assay, capable of distinguishing between coronavirus variants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current detection methods (PCR, antigen tests) are used, then pathogen detection is performed, but the methods require specialized equipment, are prone to false negatives, and cannot differentiate between active and inactive viral fragments
Solution Approach 1:
The patent replaces complex mechanical/electronic detection systems (PCR machines, antigen test devices) with a simple enzymatic assay system. The assay uses protease enzymes that naturally cleave viral proteins to generate detectable signals, eliminating the need for specialized equipment while maintaining detection capability through straightforward colorimetric or fluorescent readouts.
Solution Approach 2:
The detection system utilizes the virus's own protease enzymes as the detection mechanism. The viral proteases naturally cleave specific peptide substrates, and this self-cleavage activity serves as the detection signal. This approach eliminates the need for external reagents or complex processing, allowing the sample to detect itself through its inherent enzymatic activity.
2Reliability
If current detection methods are used, then viral presence is detected, but they cannot distinguish between active infections and inactive viral fragments
Solution Approach 1:
The patent targets specific local properties of active viral infections - the presence of functional protease enzymes with specific cleavage activities. By designing substrates that are cleaved only by active viral proteases (not by host enzymes or inactive viral fragments), the assay locally identifies the unique enzymatic fingerprint of active infections, preserving infection status information that general detection methods lose.
3Productivity
If rapid detection is implemented, then diagnostic speed is improved, but accuracy and differentiation capability may be compromised
Solution Approach 1:
The patent segments the detection process into multiple parallel enzymatic reactions, each using substrates with different amino acid sequences at the cleavage site. Different coronavirus variants exhibit distinct cleavage preferences for these segmented substrate types, allowing simultaneous rapid detection and variant differentiation through a panel of simple colorimetric or fluorescent assays.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a rapid, on-site, and accurate detection of SARS-CoV-2 and other coronaviruses, reducing false negatives and the need for specialized equipment, while identifying active infections and differentiating between variants, thus enhancing diagnostic capabilities.
Implementation Method 1
specifically designed to be cleaved by papain-like proteases, which generates a fluorescent signal when cleaved
Data Source
AI summary
The present invention relates to a method for detecting a pathogen in cellular lysate by measuring pathogen-specific enzyme activity. The method comprises contacting the cellular lysate with a substrate the pathogen of interest recognizes and modifies, and obtaining a measurable, recordable, signal. The method may comprise detection of SARS-CoV viruses using the activity of SARS PLpro enzyme in tongue scrape lysate as a readout.